These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6690033)

  • 1. Pharmacological disposition of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea in mice.
    Rahman A; Luc PV; Schein PS; Woolley PV
    Cancer Res; 1984 Jan; 44(1):149-53. PubMed ID: 6690033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacokinetics of 1-(2-chloroethyl)-3-(2,6-dioxo-1-piperidyl)-1-nitrosourea in rats and patients and extrapolation to clinical trials.
    Levin VA; Liu J; Weinkam RJ
    Cancer Res; 1981 Sep; 41(9 Pt 1):3475-7. PubMed ID: 7020928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I trial and clinical pharmacology of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea.
    Woolley PV; Luc PV; Rahman A; Korsmeyer SJ; Smith FP; Schein PS
    Cancer Res; 1981 Oct; 41(10):3896-900. PubMed ID: 7284999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of the carcinostatic agent 1-(2-chloroethyl)-3-[1'-(5'-p-nitrobenzoyl-2',3'-isopropylidene)-alpha,beta-d-ribofuranosyl]-1-nitrosourea in animals.
    Godenèche D; Madelmont JC; Moreau MF; Montoloy D; Plagne R
    Cancer Res; 1980 Sep; 40(9):3351-6. PubMed ID: 7427947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disposition and metabolism in 1-(2-chloroethyl)-3-(2',3',4'-tri-o-acetyl, ribopyranosyl)-1-nitrosourea in rats.
    Godeneche D; Moreau MF; Madelmont JC; Duprat J; Plagne R
    Cancer Res; 1982 Feb; 42(2):525-9. PubMed ID: 6799188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea in plasma by negative chemical ionization mass spectrometry.
    Smith RG; Cheung LK; Feun LG; Loo TL
    Biomed Mass Spectrom; 1983 Jul; 10(7):404-7. PubMed ID: 6616018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of phenobarbital pretreatment on the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) and 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl-1-nitrosourea (PCNU), and on the plasma pharmacokinetics and biotransformation of BCNU.
    Levin VA; Stearns J; Byrd A; Finn A; Weinkam RJ
    J Pharmacol Exp Ther; 1979 Jan; 208(1):1-6. PubMed ID: 759602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PCNU: a new nitrosourea in clinical oncology.
    Poster DS; Penta JS; Bruno S
    Am J Clin Oncol; 1982 Feb; 5(1):9-12. PubMed ID: 7081143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition and metabolism of [14C]-haloperidol in rats.
    Miyazaki H; Matsunaga Y; Nambu K; Oh-e Y; Yoshida K; Hashimoto M
    Arzneimittelforschung; 1986 Mar; 36(3):443-52. PubMed ID: 3707663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lethal activity and repair inhibition capacity of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (NSC 95466, PCNU), a nitrosourea with low carbamoylating activity.
    Drewinko B; Yang LY
    Invest New Drugs; 1983; 1(3):197-202. PubMed ID: 6678867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in patients with metastatic colorectal cancer.
    Bedikian AY; Stroehlein JR; Karlin DA; Bennetts RW; Stewart DJ; Bodey GP
    Am J Clin Oncol; 1983 Feb; 6(1):49-52. PubMed ID: 6837507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic disposition of chlorozotocin in mice.
    Mhatre RM; Green D; Panasci LC; Woolley PV; Schein PS
    Cancer Treat Rep; 1978 Aug; 62(8):1145-51. PubMed ID: 150943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of uptake of nitrosoureas by L5178Y lymphoblasts in vitro.
    Begleiter A; Lam HP; Goldenberg GJ
    Cancer Res; 1977 Apr; 37(4):1022-7. PubMed ID: 557367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and metabolism studies of two novel 1-deaza-7,8-dihydropteridines in mice.
    Noker PE; Hill DL; Kalin JR; Temple CG; Montgomery JA
    Drug Metab Dispos; 1985; 13(6):677-81. PubMed ID: 2867870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of 9-methoxy-N,N-dimethyl-5-nitropyrazolo [3,4, 5-kl]acridine-2(6H)-propanamine (PZA, PD 115934, NSC 366140) in mice: guidelines for early clinical trials1.
    Foster BJ; Wiegand RA; LoRusso PM; Baker LH
    Clin Cancer Res; 1995 Aug; 1(8):831-7. PubMed ID: 9816052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic disposition of 2-chloroethyl nitrosocarbamoylcystamine in rats.
    Godeneche D; Madelmont JC; Moreau MF; Duprat J; Chabard JL; Plagne R; Meyniel G
    Drug Metab Dispos; 1985; 13(2):220-6. PubMed ID: 2859172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II evaluation of 1-(2-chloroethyl)-3-(2,6-dioxo-(piperidyl)-1 nitrosourea (PCNU)(NSC-95466) in patients with advanced carcinoma of the lung.
    Ratanatharathorn V; Samson MK; Haas CD; Cummings GD; O'Connor EJ; Baker LH
    Am J Clin Oncol; 1983 Feb; 6(1):99-102. PubMed ID: 6837509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and metabolic disposition of 14C-metronidazole-derived radioactivity in rat after intravenous and intravaginal administration.
    Buttar HS; Siddiqui WH
    Arch Int Pharmacodyn Ther; 1980 May; 245(1):4-19. PubMed ID: 7406601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The disposition of radioactivity after administration of the anthelminthic methyl-14C-5-cyclopropylcarbonyl-2-benzimidazole carbamate (ciclobendazole) to rats and dogs.
    Brodie RR; Mayo BC; Chasseaud LF; Hawkins DR
    Arzneimittelforschung; 1977; 27(3):593-8. PubMed ID: 577426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumors.
    Feun LG; Stewart DJ; Leavens ME; Burgess MA; Savaraj N; Benjamin RS; Bodey GP
    J Neurooncol; 1983; 1(1):45-8. PubMed ID: 6678305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.